The Cancer Letter Archives
The Cancer Letter was founded in 1973, two years after Congress passed the National Cancer Act of 1971. These archives represent the first 40 years of The Cancer Letter, which is published weekly.
TCL
Vol.
30
No.
08
February 20, 2004
- Patients Sue Milken, Cancer Centers, Over Prostate Cancer Remedy PC-Spes
- Also in this 12-page issue: ASCO urges freeze of Medicare payments for chemotherapy at 2004 levels for next two years.
- NCI director creates four new deputy director positions to manage the Institute.
- Five NCAB members complete terms.
- Breast surgeon and advocate Susan Love weds surgeon Helen Cooksey in San Francisco.
- Funding opportunities listed.
- NIH Director Zerhouni to discuss Roadmap initiatives Feb. 27.
TCL
Vol.
30
No.
09
February 27, 2004
- NCI budget: a “Yes” to one thing means a “No” to something else, director says.
- Also in this 8-page issue: Bush nominates McClellan to head CMS.
- FDA to refer false statements by regulated companies to SEC.
- Sandra Horning elected ASCO president-elect.
- Medicare coverage and quality of care top ASCO’s list of policy priorities for 2004.
- NIH appoints panel to review conflict of interest rules.
- Funding opportunities listed.
- PDF file includes 8-page February issue of Business & Regulatory Report.
CCL
Vol.
27
No.
2
February 27, 2004
- Penn Begins Clinical Trial Of A Vaccine For Breast Cancer Based On Telomerase
- Radiotherapy In Combination With Zometa Provide Pain Control For Advanced Myeloma
- Breast Cancer Researchers Plan Collaborative Studies
- Breast Implants Lessen Ability Of Mammograms To Find Cancer
- Unclear Whether Clinical Trials Benefit Patients, Review Finds
- Combination of Pill, Pap Test, May Result In False Positive
- Obese Men More Likely To Have Aggressive Tumors
- $2.5 Million NCI Grant To Fund Brachytherapy Improvement
- Therapeutic Modalities Improve Patient Quality of Life In Trials
- Protocols Approved By NCI During January 2004
TCL
Vol.
30
No.
10
March 05, 2004
- FDA approval of two colon cancer therapies triggers discussion among researchers, clinicians about best treatment and clinical trial designs. CMS reimbursement pending; costs to U.S. of the new drugs could be billions per year, but some predict dramatic increases in survival.
- Also in this 8-page issue: Tony Hunter, Raymond DuBois win AACR Landon prizes.
- Funding opportunities: ASCO breast cancer research award; Lustgarten Foundation prostate cancer research award; NCI program announcements available.
TCL
Vol.
30
No.
11
March 12, 2004
- In odd aftermath of FDA Commissioner Mark McClellan’s lecture, NCI Director Andrew von Eschenbach forwards the commissioner’s thank-you note to 3,000 NCI staff. The email blast follows FDA’s return of NCI’s gift to McClellan.
- Also in this 8-page issue: NCI informatics project caBIG will “rapidly accelerate” cancer research, von Eschenbach says.
- NCI plans 18 percent budget cuts for large R01s, smaller cuts to other research project grants. NCI treatment division director Ellen Feigal accepts position with Translational Genomics Research Institute in Phoeniz, Ariz.
- In the cancer centers: San Antonio Cancer Institute gets a new director, funding commitments.
- UT Health Science Center dedicates new Children’s Cancer Research Institute.
- Funding opportunities listed.
TCL
Vol.
30
No.
12
March 19, 2004
- NCI begins rewrite of cancer center grant guidelines; will allow clinical investigator support. Goal is to implement P30-P50 working group recommendations, simplify guidelines, Karen Antman tells advisory board.
- NCI considers allowing some centers to opt out of site visits.
- Board of Scientific Advisors discussion: Are peer reviewers correctly interpreting the guidelines?
- Also in this 8-page issue: John Mendelsohn selected for BMS award. National Coalition for Cancer Survivorship and The Wellness Community begin advocacy initiative.
- Business & Regulatory Report March edition (8 pages) included.
TCL
Vol.
30
No.
13
March 26, 2004
- NCI advisors approved in concept the Institute’s plan to spend $24 million over five years for research on “patient navigator” programs.
- NCI Board of Scientific Advisors also approved a new SBIR grant program for research on circulating cells in cancer detection.
- Also in this 8-page issue: David Hohn elected board chairman of the National Comprehensive Cancer Network.
- FDA says new tools needed to speed therapeutics development.
- Senate confirms McClellan to head CMS. NCI “redeploys” $54.5 million cut from divisions to fund strategic initiatives.
- CDC study finds obesity may become leading preventable cause of death; NIH research plan drafted.
- Funding opportunities listed.
CCL
Vol.
27
No.
3
March 26, 2004
- New Treatments And Quality of Life Study For Ovarian Cancer Described At SGO
- Improved Therapies For Cervical Cancer Said To Show Promise In Clinical Trials
- Estrogen-Only HRT Little Risk In Endometrial Cancer, GOG Study Indicates
- New Treatment Modalities For Endometrial Cancer
- Clinical Trials Approved By NCI